Clinical Trial Supply & Logistics Market - By Service Type (Logistics & Distribution), Phase (Phase I, Phase II), Therapeutic Area (Oncology, Ophthalmology), End-use, Global Forecast, 2023

Description

List of Tables

Clinical Trial Supply & Logistics Market size is projected to expand at 7.9% CAGR from 2023-2032 driven by the expanding biopharmaceutical sector worldwide. The continuous innovations in drug development, particularly biologics and specialty drugs, is amplifying the demand for specialized supply and logistics services across the biopharma domain. The intricate nature of biopharmaceutical products is further necessitating tailored solutions for storage, handling, and transportation.

With the surging focus on advancing therapies with complex manufacturing processes, several pharmaceutical companies, contract research organizations (CROs), and logistics providers are entering partnerships to enhance the efficiency and reliability of clinical trial supply chains, further propelling the industry outlook. In June 2023, pharma temperature-controlled provider SkyCell joined hands with Marken to deliver upgraded transportation options for clinical trials pharmaceutical goods.

The clinical trial supply & logistics industry is segmented into service type, phase, therapeutic area, end-use, and region.

In terms of service type, the market share from the drug manufacturing segment is anticipated to depict 5.7% CAGR from 2023-2032. The ongoing efforts by pharmaceutical companies to conduct extensive clinical trials for the development of new drugs is surging the demand for efficient and reliable supply chain solutions. The rising focus on maintaining regulatory compliance and minimizing costs along with the increasing availability of specialized services for ensuring timely and secure delivery of investigational drugs from manufacturing facilities to clinical trial sites is expected to propel segment growth.

Based on end-use, the clinical trial supply & logistics market from the medical device companies segment is expected to depict 6.3% growth rate through 2032. With several medical device companies engaging in extensive clinical trials to bring innovative products to the market, the demand for efficient and specialized supply chain solutions is significantly rising. Additionally, the increasing preference for tailored services to ensure the timely and secure delivery of investigational medical devices to clinical trial sites is anticipated to fuel the segment growth.

Regionally, the Europe clinical trial supply and logistics industry held sizable revenue share in 2022 and is set to exhibit 7.8% growth rate between 2023 and 2032 propelled by the thriving pharmaceutical and biotechnology sectors. Europe has emerged as a prominent hub for global clinical trials owing to the presence of an established infrastructure, regulatory frameworks, and experienced clinical research landscape, further surging the demand for specialized supply chain and logistics services.

Several industry participants are also offering more streamlined solutions to healthcare organizations to address the logistic issues propelled by the increased development of new medicines. For instance, in October 2023, UPS Healthcare launched UPS Pickup Point sites in the U.K., France, Italy, Germany, and Spain to provide a new reverse logistics service for health laboratory clients.

Product Code: 6853

Chapter 1 Methodology & Scope

1.1 Market definition & scope
1.2 Base estimates & calculations
- 1.2.1 Data collection
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Global clinical trial supply & logistics industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Service type trends
- 2.1.4 Phase trends
- 2.1.5 Therapeutic area trends
- 2.1.6 End-use trends

Chapter 3 Clinical Trial Supply & Logistics Industry Insights

3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032 (USD Million)
3.3 Industry impact forces
- 3.3.1 Growth drivers
  - 3.3.1.1 Increasing number of clinical trials
  - 3.3.1.2 Globalization of clinical trials
  - 3.3.1.3 Increasing outsourcing of clinical trial services
- 3.3.2 Industry pitfalls & challenges
  - 3.3.2.1 Stringent regulatory requirements and varying regulations
  - 3.3.2.2 Limited infrastructure in developing countries
3.4 Growth potential analysis
- 3.4.1 By service type
- 3.4.2 By phase
- 3.4.3 By therapeutic area
- 3.4.4 By end-use
3.5 COVID-19 impact analysis
3.6 Technology landscape
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022

Chapter 5 Clinical Trial Supply & Logistics Market, By Service Type, 2018 - 2032 (USD Million)

5.1 Key trends, by service type
5.2 Logistics & distribution
5.3 Storage & retention
5.4 Packaging, labeling & blinding
5.5 Drug manufacturing
5.6 Comparator sourcing
5.7 Other services

Chapter 6 Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2032 (USD Million)

6.1 Key trends, by phase
6.2 Phase I
6.3 Phase II
6.4 Phase III
6.5 Phase IV

Chapter 7 Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2032 (USD Million)

7.1 Key trends, by therapeutic area
7.2 Oncology
7.3 Infectious diseases
7.4 Cardiovascular diseases
7.5 Ophthalmology
7.6 Dermatology
7.7 Autoimmune disease
7.8 Other therapeutic areas

Chapter 8 Clinical Trial Supply & Logistics Market, By End-use, 2018 - 2032 (USD Million)

8.1 Key trends, by end-use
8.2 Pharmaceutical & biotechnology companies
8.3 Contract Research Organizations (CROs)
8.4 Medical device companies
8.5 Other end-users

Chapter 9 Clinical Trial Supply & Logistics Market, By Region, 2018 - 2032 (USD Million)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 MEA
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 Rest of MEA

Chapter 10 Company Profiles

10.1 Thermo Fisher Scientific Inc. (Patheon)
10.2 Catalent, Inc.
10.3 Parexel
10.4 Almac Group
10.5 Marken
10.6 Piramal Pharma Solutions
10.7 UDG Healthcare
10.8 DHL
10.9 Movianto
10.10 Packaging Coordinators Inc.